Skip to main content
Top
Published in: Rheumatology International 6/2011

01-06-2011 | Original Article

Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status

Authors: Yesim Garip, Filiz Eser, Hatice Bodur

Published in: Rheumatology International | Issue 6/2011

Login to get access

Abstract

Quality of life (QoL) is the gratification taken from life, happiness, and the way human beings perceive their situation within the system of culture and values. Rheumatoid arthritis (RA) is among the main conditions in which QoL is decreased. The aim of this study was to evaluate QoL and related variables in patients with RA. A total of 153 RA patients were included in the study. All patients were evaluated by the rheumatoid arthritis quality of life (RAQoL), Nottingham health profile (NHP), and the health assessment questionnaire (HAQ) scales. Disease activity score 28 (DAS28) was used for measuring disease activity, while the modified Sharp score developed by Van der Heijde was used for evaluating the radiological damage, and visual analog scale-pain (VAS-pain) was used to determine the level of pain. RAQoL had linear relations at high levels with VAS-pain, HAQ, DAS28, and the modified Sharp score (r values 0.86, 0.82, 0.82, and 0.38, respectively) and at a moderate level with disease duration (r 0.18). VAS-pain showed the highest correlation with the pain subgroup of NHP (r 0.91) and the second highest correlation was with RAQoL (r 0.86). As a result, it is concluded that in RA patients RAQoL is an important scale reflecting QoL related with pain, disease activity, functional status, and radiological progression. In our study pain ranked first among the variables that influenced QoL, and this was followed by disease activity and functional status.
Literature
1.
go back to reference Balsa A, Pascual-Salcedo D, Martin J (2007) Antibodies to citrullinated peptides in rheumathoid arthritis. Med Clin (Barc) 128:668–673CrossRef Balsa A, Pascual-Salcedo D, Martin J (2007) Antibodies to citrullinated peptides in rheumathoid arthritis. Med Clin (Barc) 128:668–673CrossRef
2.
go back to reference Pollard L, Choy EH, Scott DL (2005) The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 23:43–52 Pollard L, Choy EH, Scott DL (2005) The consequences of rheumatoid arthritis: quality of life measures in the individual patient. Clin Exp Rheumatol 23:43–52
3.
go back to reference Whalley D, Mc Kenna SP, De Jong Z, Heijde VD (1997) Quality of life in RA. Br J Rheumatol 36:884–888PubMedCrossRef Whalley D, Mc Kenna SP, De Jong Z, Heijde VD (1997) Quality of life in RA. Br J Rheumatol 36:884–888PubMedCrossRef
4.
go back to reference Prevoo MLL, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44–48PubMedCrossRef Prevoo MLL, van’t Hof MA, Kuper HH et al (1995) Modified disease activity scores that include twenty-eight-joint counts. Arthritis Rheum 38:44–48PubMedCrossRef
5.
go back to reference Sokka T (2008) Radiographic scoring in rheumatoid arthritis. Bull NYU Hosp Jt Dis 5:15–18 Sokka T (2008) Radiographic scoring in rheumatoid arthritis. Bull NYU Hosp Jt Dis 5:15–18
6.
go back to reference Price DD, McGrath P, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17:45–56PubMedCrossRef Price DD, McGrath P, Rafii A, Buckingham B (1983) The validation of visual analogue scales as ratio scale measures for chronic and experimental pain. Pain 17:45–56PubMedCrossRef
7.
go back to reference Kucukdeveci AA, Mc Kenna SP, Kutlay S et al (2000) The development and psycometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23:31–38PubMedCrossRef Kucukdeveci AA, Mc Kenna SP, Kutlay S et al (2000) The development and psycometric assessment of the Turkish version of the Nottingham health profile. Int J Rehabil Res 23:31–38PubMedCrossRef
8.
go back to reference Kutlay S, Kucukdeveci AA, Gonul DD, Tennant A (2003) Adaptation and validation of the Turkish version of the rheumatoid arthritis quality of life scale. Rheumatol Int 23:21–26PubMed Kutlay S, Kucukdeveci AA, Gonul DD, Tennant A (2003) Adaptation and validation of the Turkish version of the rheumatoid arthritis quality of life scale. Rheumatol Int 23:21–26PubMed
9.
go back to reference Kucukdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford health assessment questionnaire. Arthritis Rheum 51:14–19PubMedCrossRef Kucukdeveci AA, Sahin H, Ataman S, Griffiths B, Tennant A (2004) Issues in cross-cultural validity: example from the adaptation, reliability, and validity testing of a Turkish version of the Stanford health assessment questionnaire. Arthritis Rheum 51:14–19PubMedCrossRef
10.
go back to reference Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R (2007) Impact of RA on quality of life. Mod Rheumatol 17:290–295PubMedCrossRef Haroon N, Aggarwal A, Lawrence A, Agarwal V, Misra R (2007) Impact of RA on quality of life. Mod Rheumatol 17:290–295PubMedCrossRef
11.
go back to reference Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH (2005) A comparison of generic. indirect utility measures (the HUI2. HUI3. SF-6D. and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60:1571–1582PubMedCrossRef Marra CA, Woolcott JC, Kopec JA, Shojania K, Offer R, Brazier JE, Esdaile JM, Anis AH (2005) A comparison of generic. indirect utility measures (the HUI2. HUI3. SF-6D. and the EQ-5D) and disease-specific instruments (the RAQoL and the HAQ) in rheumatoid arthritis. Soc Sci Med 60:1571–1582PubMedCrossRef
12.
go back to reference Rupp I, Boshuizen HC, Dinant HJ, Jacobi CE, van den Bos GA (2006) Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain and depressive symptoms. Scand J Rheumatol 35:175–181PubMedCrossRef Rupp I, Boshuizen HC, Dinant HJ, Jacobi CE, van den Bos GA (2006) Disability and health-related quality of life among patients with rheumatoid arthritis: association with radiographic joint damage, disease activity, pain and depressive symptoms. Scand J Rheumatol 35:175–181PubMedCrossRef
13.
go back to reference Häkkinen A, Kautiainen H, Hannonen P, Ylinen J, Arkela-Kautiainen M, Sokka T (2005) Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis 64:59–63PubMedCrossRef Häkkinen A, Kautiainen H, Hannonen P, Ylinen J, Arkela-Kautiainen M, Sokka T (2005) Pain and joint mobility explain individual subdimensions of the health assessment questionnaire (HAQ) disability index in patients with rheumatoid arthritis. Ann Rheum Dis 64:59–63PubMedCrossRef
14.
go back to reference Prajs K, Fliciński J, Brzosko I, Przepiera-Bedzak H, Ostanek L, Brzosko M (2006) Quality of life and activity of disease in patients with rheumatoid arthritis. Ann Acad Med Stetin 52:39–43PubMed Prajs K, Fliciński J, Brzosko I, Przepiera-Bedzak H, Ostanek L, Brzosko M (2006) Quality of life and activity of disease in patients with rheumatoid arthritis. Ann Acad Med Stetin 52:39–43PubMed
15.
go back to reference Prajs K (2007) The quality of life of patients who suffer from rheumatoid arthritis in reference to their physical fitness and mental state. Ann Acad Med Stetin 53:72–82PubMed Prajs K (2007) The quality of life of patients who suffer from rheumatoid arthritis in reference to their physical fitness and mental state. Ann Acad Med Stetin 53:72–82PubMed
16.
go back to reference Houssien DA, McKenna SP, Scott D (1997) The Nottingham health profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36:69–73PubMedCrossRef Houssien DA, McKenna SP, Scott D (1997) The Nottingham health profile as a measure of disease activity and outcome in rheumatoid arthritis. Br J Rheumatol 36:69–73PubMedCrossRef
17.
go back to reference Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor BuchbinderR (1999) Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR task force on generic quality of life. Life outcome measures in rheumatology. International league of associations for rheumatology. J Rheumatol 26:217–221PubMed Wells G, Boers M, Shea B, Tugwell P, Westhovens R, Saurez-Almazor BuchbinderR (1999) Sensitivity to change of generic quality of life instruments in patients with rheumatoid arthritis: preliminary findings in the generic health OMERACT study. OMERACT/ILAR task force on generic quality of life. Life outcome measures in rheumatology. International league of associations for rheumatology. J Rheumatol 26:217–221PubMed
Metadata
Title
Health-related quality of life in rheumatoid arthritis: comparison of RAQoL with other scales in terms of disease activity, severity of pain, and functional status
Authors
Yesim Garip
Filiz Eser
Hatice Bodur
Publication date
01-06-2011
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 6/2011
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-009-1353-1

Other articles of this Issue 6/2011

Rheumatology International 6/2011 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine